-
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-19-290)
National Cancer Institute
Application Receipt Date(s): October 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
(PAR-19-291)
National Cancer Institute
Application Receipt Date(s): October 18, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed)
(PAR-19-292)
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
The first standard application due date for this FOA is October 5, 2019.
-
Development of Novel and Robust Systems for Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R21 Clinical Trial Not Allowed)
(PAR-19-293)
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. ?The first standard application due date for this FOA is October 16, 2019
-
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
(PAR-19-294)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): Nov 12, 2019, July 14, 2020, Nov 12, 2020, July 14, 2021, and Nov 12, 2021, by 5:00 PM local time of applicant organization.
All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Research to Understand and Inform Interventions that Promote the Research Careers of Individuals in the Biomedical Sciences (R01 - Clinical Trial Not Allowed)
(PAR-19-295)
National Institute of General Medical Sciences
Application Receipt Date(s): October 15, 2020; October 13, 2021
All applications are due by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on the listed dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
(PAR-19-296)
National Institute of Allergy and Infectious Diseases
Application Receipt Date(s): November 4, 2019 , October 14, 2020, October 13, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Interpersonal Processes in Alzheimer's Disease and Related Dementias Clinical Interactions and Care Partnerships (R01 Clinical Trial Optional)
(RFA-AG-20-006)
National Institute on Aging
Application Receipt Date(s): October 23, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
No late applications will be accepted for this Funding Opportunity Announcement.
-
Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
(RFA-AG-20-019)
National Institute on Aging
Application Receipt Date(s): October 2, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Biology of Aging in Reproductive Tissues (R01 Clinical Trial Not Allowed)
(RFA-AG-20-036)
National Institute on Aging
Application Receipt Date(s): January 29, 2020, by 5:00 PM local time of applicant organization. No late applications will be accepted for this Funding Opportunity Announcement.
-
Drug Development Tools Research Grants (U01 Clinical Trial Not Allowed)
(RFA-FD-19-028)
Food and Drug Administration
Application Receipt Date(s): August 5, 2019, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Advancing Novel Research Models to Study Idiopathic Pulmonary Fibrosis (U01 Clinical Trial Not Allowed)
(RFA-HL-20-007)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
-
Pediatric Cardiac Genomics Consortium (U01 - Clinical Trial Not Allowed)
(RFA-HL-20-015)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 2, 2019
-
Cardiovascular Developmental Biology Data Resource Center (U01 - Clinical Trial Not Allowed)
(RFA-HL-20-017)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 2, 2019, by 5:00 PM local time of applicant organization.
-
Diversity Program Consortium Dissemination and Translation Awards (U01 - Clinical Trial Not Allowed)
(RFA-RM-19-003)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): October 8, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.